Your browser doesn't support javascript.
loading
Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child.
Ullrich, Christina K; Rodday, Angie Mae; Bingen, Kristin; Kupst, Mary Jo; Patel, Sunita K; Syrjala, Karen L; Harris, Lynnette L; Recklitis, Christopher J; Schwartz, Lisa; Davies, Stella; Guinan, Eva C; Chang, Grace; Wolfe, Joanne; Parsons, Susan K.
Afiliação
  • Ullrich CK; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts; Departmen
  • Rodday AM; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.
  • Bingen K; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Kupst MJ; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Patel SK; Departments of Population Sciences and Supportive Care Medicine, City of Hope Medical Center, Duarte, California.
  • Syrjala KL; Biobehavioral Sciences Department, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Harris LL; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Recklitis CJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Schwartz L; Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania.
  • Davies S; Division of Bone Marrow Transplant and Immune Deficiency Cincinnati Children's Hospital Medical Center Cincinnati, Ohio.
  • Guinan EC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Chang G; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
  • Wolfe J; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Parsons SK; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts; Department of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts.
Biol Blood Marrow Transplant ; 22(1): 104-11, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26348891
Pediatric hematopoietic stem cell transplantation (HSCT) offers cure for high-risk malignancies and other conditions, but carries a risk of complications. Parental outlook regarding their child's transplantation course and future health has been largely unexplored. This report presents the Parent Outlook Scale, describes its properties, and examines the outlook of parents embarking on their child's transplantation course and the associated variables. Parents of children scheduled to undergo HSCT (n = 363) at 8 US transplantation centers completed the Parent Outlook Scale, comprising 4 items assessing frequency of the parent's thoughts about the potential difficulty of the child's transplantation (Transplant Difficult subscale) and worsened health (Health Worse subscale). Item responses were rated on a 5-point Likert scale (ranging from "none" to "all of the time") and, along with scale/subscale scores, transformed to 100-point scales, with higher scores connoting greater thought frequency. Psychometrics were explored. Multivariable models identified personal and clinical characteristics associated with scale and subscale scores. The Parent Outlook Scale (α = 0.75) and subscales were found to have sound psychometric properties. Factor loading supported the single scale with 2 subscales representing distinct aspects of overall outlook. Mean scores (Parent Outlook, 52.5 ± 21.7; Transplant Difficult, 64.4 ± 25.6; Health Worse, 40.7 ± 25.7) revealed variability within and across scale/subscales. Significantly different mean subscale scores (P < .001) indicated more frequent Transplant Difficult thoughts than Health Worse thoughts. Clinical factors (solid tumor diagnosis and unrelated donor transplant) and a parent factor (worse emotional functioning) were associated with higher scale and subscale scores. Our findings show that the outlook of parents embarking on their child's HSCT course is varied and not solely a product of clinical factors readily apparent to clinicians. Referring and transplantation clinicians should create opportunities to explore with parents their perspectives and concerns before and during the course of HSCT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pais / Transplante de Células-Tronco Hematopoéticas / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pais / Transplante de Células-Tronco Hematopoéticas / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article